> 0 1 0 1 O
= 1 2 1 2 O
2 3 4 3 4 B-lower_bound
weeks 5 10 5 10 I-lower_bound
since 11 16 11 16 O
major 17 22 17 22 B-treatment
surgery 23 30 23 30 I-treatment

Absolute 0 8 31 39 B-clinical_variable
neutrophil 9 19 40 50 I-clinical_variable
count 20 25 51 56 I-clinical_variable
( 26 27 57 58 I-clinical_variable
ANC 27 30 58 61 I-clinical_variable
) 30 31 61 62 I-clinical_variable
> 32 33 63 64 O
= 33 34 64 65 O
1.0 35 38 66 69 B-lower_bound
x 39 40 70 71 I-lower_bound
10 41 43 72 74 I-lower_bound
^ 43 44 74 75 I-lower_bound
9 44 45 75 76 I-lower_bound
/ 45 46 76 77 I-lower_bound
L 46 47 77 78 I-lower_bound
within 48 54 79 85 O
14 55 57 86 88 B-upper_bound
days 58 62 89 93 I-upper_bound
prior 63 68 94 99 I-upper_bound
to 69 71 100 102 O
starting 72 80 103 111 O
therapy 81 88 112 119 B-treatment

Active 0 6 120 126 O
central 7 14 127 134 B-chronic_disease
nervous 15 22 135 142 I-chronic_disease
system 23 29 143 149 I-chronic_disease
( 30 31 150 151 I-chronic_disease
CNS 31 34 151 154 I-chronic_disease
) 34 35 154 155 I-chronic_disease
disease 36 43 156 163 I-chronic_disease
defined 44 51 164 171 O
as 52 54 172 174 O
symptomatic 55 66 175 186 O
meningeal 67 76 187 196 B-chronic_disease
lymphoma 77 85 197 205 I-chronic_disease
or 86 88 206 208 O
known 89 94 209 214 O
CNS 95 98 215 218 O
parenchymal 99 110 219 230 B-chronic_disease
lymphoma 111 119 231 239 I-chronic_disease
; 119 120 239 240 O
a 121 122 241 242 O
lumbar 123 129 243 249 O
puncture 130 138 250 258 O
demonstrating 139 152 259 272 O
DLBCL 153 158 273 278 B-cancer
at 159 161 279 281 O
the 162 165 282 285 O
time 166 170 286 290 O
of 171 173 291 293 O
registration 174 186 294 306 O
to 187 189 307 309 O
this 190 194 310 314 O
study 195 200 315 320 O
is 201 203 321 323 O
not 204 207 324 327 O
exclusion 208 217 328 337 O
for 218 221 338 341 O
study 222 227 342 347 O
enrollment 228 238 348 358 O

Ann 0 3 359 362 B-clinical_variable
Arbor 4 9 363 368 I-clinical_variable
stage 10 15 369 374 B-lower_bound
I 16 17 375 376 I-lower_bound
to 18 20 377 379 O
stage 21 26 380 385 B-upper_bound
IV 27 29 386 388 I-upper_bound
DLBCL 30 35 389 394 B-cancer
at 36 38 395 397 O
the 39 42 398 401 O
time 43 47 402 406 O
of 48 50 407 409 O
relapsed 51 59 410 418 O
/ 59 60 418 419 O
refractory 60 70 419 429 O
disease 71 78 430 437 O
to 79 81 438 440 O
be 82 84 441 443 O
eligible 85 93 444 452 O

Chemotherapy 0 12 453 465 B-treatment
within 13 19 466 472 O
3 20 21 473 474 B-upper_bound
weeks 22 27 475 480 I-upper_bound
of 28 30 481 483 O
the 31 34 484 487 O
first 35 40 488 493 O
scheduled 41 50 494 503 O
study 51 56 504 509 O
treatment 57 66 510 519 B-treatment

Females 0 7 520 527 B-gender
of 8 10 528 530 O
childbearing 11 23 531 543 O
potential 24 33 544 553 O
( 34 35 554 555 O
FCBP 35 39 555 559 O
) 39 40 559 560 O
must 41 45 561 565 O
agree 46 51 566 571 O
to 52 54 572 574 O
ongoing 55 62 575 582 B-pregnancy
pregnancy 63 72 583 592 I-pregnancy
testing 73 80 593 600 O
and 81 84 601 604 O
to 85 87 605 607 O
practice 88 96 608 616 B-contraception_consent
contraception 97 110 617 630 I-contraception_consent

HBV 0 3 631 634 B-clinical_variable
DNA 4 7 635 638 I-clinical_variable
is 8 10 639 641 O
negative 11 19 642 650 O
, 19 20 650 651 O
the 21 24 652 655 O
subject 25 32 656 663 O
may 33 36 664 667 O
be 37 39 668 670 O
included 40 48 671 679 O
but 49 52 680 683 O
must 53 57 684 688 O
undergo 58 65 689 696 O
at 66 68 697 699 O
least 69 74 700 705 O
every 75 80 706 711 O
2 81 82 712 713 B-lower_bound
months 83 89 714 720 I-lower_bound
HBV 90 93 721 724 O
DNA 94 97 725 728 O
polymerase 98 108 729 739 O
chain 109 114 740 745 O
reaction 115 123 746 754 O
( 124 125 755 756 O
PCR 125 128 756 759 O
) 128 129 759 760 O
testing 130 137 761 768 O
from 138 142 769 773 O
the 143 146 774 777 O
start 147 152 778 783 O
of 153 155 784 786 O
treatment 156 165 787 796 B-treatment
throughout 166 176 797 807 O
the 177 180 808 811 O
duration 181 189 812 820 O
the 190 193 821 824 O
treatment 194 203 825 834 O
course 204 210 835 841 O

HBV 0 3 842 845 B-chronic_disease
DNA 4 7 846 849 I-chronic_disease
is 8 10 850 852 O
positive 11 19 853 861 O
, 19 20 861 862 O
the 21 24 863 866 O
subject 25 32 867 874 O
will 33 37 875 879 O
be 38 40 880 882 O
excluded 41 49 883 891 O
from 50 54 892 896 O
the 55 58 897 900 O
study 59 64 901 906 O

Hemoglobin 0 10 907 917 B-clinical_variable
> 11 12 918 919 O
= 12 13 919 920 O
8 14 15 921 922 B-lower_bound
g 16 17 923 924 I-lower_bound
/ 17 18 924 925 I-lower_bound
dL 18 20 925 927 I-lower_bound
( 21 22 928 929 I-lower_bound
80 22 24 929 931 I-lower_bound
g 25 26 932 933 I-lower_bound
/ 26 27 933 934 I-lower_bound
L 27 28 934 935 I-lower_bound
) 28 29 935 936 I-lower_bound
within 30 36 937 943 O
14 37 39 944 946 B-upper_bound
days 40 44 947 951 I-upper_bound
prior 45 50 952 957 I-upper_bound
to 51 53 958 960 O
randomization 54 67 961 974 B-treatment
( 68 69 975 976 O
subjects 69 77 976 984 O
may 78 81 985 988 O
be 82 84 989 991 O
receiving 85 94 992 1001 O
red 95 98 1002 1005 B-treatment
blood 99 104 1006 1011 I-treatment
cell 105 109 1012 1016 I-treatment
[ 110 111 1017 1018 I-treatment
RBC 111 114 1018 1021 I-treatment
] 114 115 1021 1022 I-treatment
transfusions 116 128 1023 1035 I-treatment
in 129 131 1036 1038 O
accordance 132 142 1039 1049 O
with 143 147 1050 1054 O
institutional 148 161 1055 1068 O
guidelines 162 172 1069 1079 O
) 172 173 1079 1080 O

Hepatitis 0 9 1081 1090 B-chronic_disease
B 10 11 1091 1092 I-chronic_disease
surface 12 19 1093 1100 I-chronic_disease
antigen 20 27 1101 1108 I-chronic_disease
( 28 29 1109 1110 I-chronic_disease
HBsAg 29 34 1110 1115 I-chronic_disease
) 34 35 1115 1116 I-chronic_disease
negative 36 44 1117 1125 O
, 44 45 1125 1126 O
hepatitis 46 55 1127 1136 B-chronic_disease
B 56 57 1137 1138 I-chronic_disease
core 58 62 1139 1143 I-chronic_disease
antibody 63 71 1144 1152 I-chronic_disease
( 72 73 1153 1154 I-chronic_disease
HBcAb 73 78 1154 1159 I-chronic_disease
) 78 79 1159 1160 I-chronic_disease
negative 80 88 1161 1169 O
, 88 89 1169 1170 O
hepatitis 90 99 1171 1180 B-chronic_disease
B 100 101 1181 1182 I-chronic_disease
surface 102 109 1183 1190 I-chronic_disease
antibody 110 118 1191 1199 I-chronic_disease
( 119 120 1200 1201 I-chronic_disease
HBsAb 120 125 1201 1206 I-chronic_disease
) 125 126 1206 1207 I-chronic_disease
positive 127 135 1208 1216 O
patients 136 144 1217 1225 O

Histological 0 12 1226 1238 O
confirmation 13 25 1239 1251 O
of 26 28 1252 1254 O
relapsed 29 37 1255 1263 O
/ 37 38 1263 1264 O
refractory 38 48 1264 1274 O
CD20 49 53 1275 1279 B-cancer
positive 54 62 1280 1288 O
diffuse 63 70 1289 1296 O
large 71 76 1297 1302 O
B 77 78 1303 1304 B-cancer
- 78 79 1304 1305 I-cancer
cell 79 83 1305 1309 I-cancer
lymphoma 84 92 1310 1318 I-cancer

Karnofsky 0 9 1319 1328 B-clinical_variable
score 10 15 1329 1334 I-clinical_variable
( 16 17 1335 1336 I-clinical_variable
KS 17 19 1336 1338 I-clinical_variable
) 19 20 1338 1339 I-clinical_variable
> 21 22 1340 1341 O
= 22 23 1341 1342 O
50 24 26 1343 1345 B-lower_bound

Known 0 5 1346 1351 O
history 6 13 1352 1359 O
of 14 16 1360 1362 O
allergy 17 24 1363 1370 O
to 25 27 1371 1373 O
Captisol 28 36 1374 1382 B-allergy_name
( 37 38 1383 1384 O
a 38 39 1384 1385 O
cyclodextrin 40 52 1386 1398 B-allergy_name
derivative 53 63 1399 1409 B-allergy_name
used 64 68 1410 1414 O
to 69 71 1415 1417 O
solubilize 72 82 1418 1428 O
carfilzomib 83 94 1429 1440 B-allergy_name
) 94 95 1440 1441 O

Known 0 5 1442 1447 O
to 6 8 1448 1450 O
be 9 11 1451 1453 O
seropositive 12 24 1454 1466 O
for 25 28 1467 1470 O
human 29 34 1471 1476 B-chronic_disease
immunodeficiency 35 51 1477 1493 I-chronic_disease
virus 52 57 1494 1499 I-chronic_disease
( 58 59 1500 1501 I-chronic_disease
HIV 59 62 1501 1504 I-chronic_disease
) 62 63 1504 1505 I-chronic_disease
; 63 64 1505 1506 O
an 65 67 1507 1509 O
HIV 68 71 1510 1513 O
test 72 76 1514 1518 O
is 77 79 1519 1521 O
not 80 83 1522 1525 O
required 84 92 1526 1534 O
for 93 96 1535 1538 O
entry 97 102 1539 1544 O
on 103 105 1545 1547 O
this 106 110 1548 1552 O
protocol 111 119 1553 1561 O
, 119 120 1561 1562 O
but 121 124 1563 1566 O
is 125 127 1567 1569 O
required 128 136 1570 1578 O
if 137 139 1579 1581 O
the 140 143 1582 1585 O
patient 144 151 1586 1593 O
is 152 154 1594 1596 O
perceived 155 164 1597 1606 O
to 165 167 1607 1609 O
be 168 170 1610 1612 O
at 171 173 1613 1615 O
risk 174 178 1616 1620 O

Less 0 4 1621 1625 O
than 5 9 1626 1630 O
2 10 11 1631 1632 B-upper_bound
- 11 12 1632 1633 I-upper_bound
years 12 17 1633 1638 I-upper_bound
disease 18 25 1639 1646 O
free 26 30 1647 1651 O
from 31 35 1652 1656 O
another 36 43 1657 1664 O
primary 44 51 1665 1672 B-cancer
malignancy 52 62 1673 1683 I-cancer
( 63 64 1684 1685 O
other 64 69 1685 1690 O
than 70 74 1691 1695 O
squamous 75 83 1696 1704 B-cancer
or 84 86 1705 1707 O
basal 87 92 1708 1713 B-cancer
cell 93 97 1714 1718 I-cancer
carcinoma 98 107 1719 1728 I-cancer
of 108 110 1729 1731 O
the 111 114 1732 1735 O
skin 115 119 1736 1740 O
, 119 120 1740 1741 O
in 121 123 1742 1744 B-cancer
- 123 124 1744 1745 I-cancer
situ 124 128 1745 1749 I-cancer
carcinoma 129 138 1750 1759 I-cancer
of 139 141 1760 1762 O
the 142 145 1763 1766 O
cervix 146 152 1767 1773 O
or 153 155 1774 1776 O
breast 156 162 1777 1783 O
, 162 163 1783 1784 O
superficial 164 175 1785 1796 O
bladder 176 183 1797 1804 B-cancer
carcinoma 184 193 1805 1814 I-cancer
, 193 194 1814 1815 O
or 195 197 1816 1818 O
previously 198 208 1819 1829 O
treated 209 216 1830 1837 O
localized 217 226 1838 1847 O
prostate 227 235 1848 1856 B-cancer
cancer 236 242 1857 1863 I-cancer
with 243 247 1864 1868 O
normal 248 254 1869 1875 O
prostate 255 263 1876 1884 B-clinical_variable
- 263 264 1884 1885 I-clinical_variable
specific 264 272 1885 1893 I-clinical_variable
antigen 273 280 1894 1901 I-clinical_variable
[ 281 282 1902 1903 I-clinical_variable
PSA 282 285 1903 1906 I-clinical_variable
] 285 286 1906 1907 I-clinical_variable
levels 287 293 1908 1914 I-clinical_variable
) 293 294 1914 1915 O

Life 0 4 1916 1920 B-clinical_variable
expectancy 5 15 1921 1931 I-clinical_variable
> 16 17 1932 1933 O
= 17 18 1933 1934 O
3 19 20 1935 1936 B-lower_bound
months 21 27 1937 1943 I-lower_bound

Major 0 5 1944 1949 B-treatment
surgery 6 13 1950 1957 I-treatment
, 13 14 1957 1958 O
other 15 20 1959 1964 O
than 21 25 1965 1969 O
diagnostic 26 36 1970 1980 O
surgery 37 44 1981 1988 O
, 44 45 1988 1989 O
within 46 52 1990 1996 O
2 53 54 1997 1998 B-upper_bound
weeks 55 60 1999 2004 I-upper_bound

Male 0 4 2005 2009 B-gender
subjects 5 13 2010 2018 I-gender
must 14 18 2019 2023 O
agree 19 24 2024 2029 B-contraception_consent
to 25 27 2030 2032 I-contraception_consent
practice 28 36 2033 2041 I-contraception_consent
contraception 37 50 2042 2055 I-contraception_consent

Measurable 0 10 2056 2066 O
or 11 13 2067 2069 O
assessable 14 24 2070 2080 O
disease 25 32 2081 2088 O
is 33 35 2089 2091 O
required 36 44 2092 2100 O
; 44 45 2100 2101 O
measurable 46 56 2102 2112 O
tumor 57 62 2113 2118 B-clinical_variable
size 63 67 2119 2123 I-clinical_variable
( 68 69 2124 2125 O
at 69 71 2125 2127 O
least 72 77 2128 2133 O
one 78 81 2134 2137 O
node 82 86 2138 2142 O
measuring 87 96 2143 2152 O
2.25 97 101 2153 2157 B-lower_bound
cm^2 102 106 2158 2162 I-lower_bound
in 107 109 2163 2165 O
bidimensional 110 123 2166 2179 O
measurement 124 135 2180 2191 O
) 135 136 2191 2192 O
per 137 140 2193 2196 O
computed 141 149 2197 2205 B-treatment
tomography 150 160 2206 2216 I-treatment
( 161 162 2217 2218 I-treatment
CT 162 164 2218 2220 I-treatment
) 164 165 2220 2221 I-treatment
scan 166 170 2222 2226 I-treatment
, 170 171 2226 2227 O
other 172 177 2228 2233 O
radiological 178 190 2234 2246 B-treatment
study 191 196 2247 2252 I-treatment
, 196 197 2252 2253 O
and/or 198 204 2254 2260 O
physical 205 213 2261 2269 B-treatment
exam 214 218 2270 2274 I-treatment

Medical 0 7 2275 2282 O
condition 8 17 2283 2292 O
requiring 18 27 2293 2302 O
chronic 28 35 2303 2310 O
use 36 39 2311 2314 O
of 40 42 2315 2317 O
high 43 47 2318 2322 B-treatment
dose 48 52 2323 2327 I-treatment
systemic 53 61 2328 2336 I-treatment
corticosteroids 62 77 2337 2352 I-treatment
( 78 79 2353 2354 O
i.e. 79 83 2354 2358 O
, 83 84 2358 2359 O
doses 85 90 2360 2365 O
of 91 93 2366 2368 O
prednisone 94 104 2369 2379 B-treatment
higher 105 111 2380 2386 O
than 112 116 2387 2391 O
10 117 119 2392 2394 B-lower_bound
mg 120 122 2395 2397 I-lower_bound
/ 122 123 2397 2398 I-lower_bound
day 123 126 2398 2401 I-lower_bound
or 127 129 2402 2404 O
equivalent 130 140 2405 2415 O
) 140 141 2415 2416 O

Myocardial 0 10 2417 2427 B-chronic_disease
infarct 11 18 2428 2435 I-chronic_disease
within 19 25 2436 2442 O
6 26 27 2443 2444 B-upper_bound
months 28 34 2445 2451 I-upper_bound
before 35 41 2452 2458 O
enrollment 42 52 2459 2469 O

New 0 3 2470 2473 B-clinical_variable
York 4 8 2474 2478 I-clinical_variable
Heart 9 14 2479 2484 I-clinical_variable
Association 15 26 2485 2496 I-clinical_variable
( 27 28 2497 2498 I-clinical_variable
NYHA 28 32 2498 2502 I-clinical_variable
) 32 33 2502 2503 I-clinical_variable
class 34 39 2504 2509 I-clinical_variable
II 40 42 2510 2512 B-lower_bound
or 43 45 2513 2515 O
greater 46 53 2516 2523 O
heart 54 59 2524 2529 B-chronic_disease
failure 60 67 2530 2537 I-chronic_disease
, 67 68 2537 2538 O
uncontrolled 69 81 2539 2551 B-chronic_disease
angina 82 88 2552 2558 I-chronic_disease
, 88 89 2558 2559 O
severe 90 96 2560 2566 O
uncontrolled 97 109 2567 2579 O
ventricular 110 121 2580 2591 B-chronic_disease
arrhythmias 122 133 2592 2603 I-chronic_disease
, 133 134 2603 2604 O
clinically 135 145 2605 2615 O
significant 146 157 2616 2627 O
pericardial 158 169 2628 2639 B-chronic_disease
disease 170 177 2640 2647 I-chronic_disease
, 177 178 2647 2648 O
or 179 181 2649 2651 O
electrocardiographic 182 202 2652 2672 B-treatment
evidence 203 211 2673 2681 O
of 212 214 2682 2684 O
acute 215 220 2685 2690 O
ischemia 221 229 2691 2699 B-chronic_disease

No 0 2 2700 2702 O
known 3 8 2703 2708 O
hypersensitivity 9 25 2709 2725 O
to 26 28 2726 2728 O
murine 29 35 2729 2735 B-allergy_name
products 36 44 2736 2744 I-allergy_name

Patient 0 7 2745 2752 O
has 8 11 2753 2756 O
received 12 20 2757 2765 O
other 21 26 2766 2771 O
investigational 27 42 2772 2787 B-treatment
drugs 43 48 2788 2793 I-treatment
within 49 55 2794 2800 O
4 56 57 2801 2802 B-upper_bound
weeks 58 63 2803 2808 I-upper_bound
before 64 70 2809 2815 I-upper_bound
enrollment 71 81 2816 2826 O

Patients 0 8 2827 2835 O
must 9 13 2836 2840 O
have 14 18 2841 2845 O
normal 19 25 2846 2852 O
baseline 26 34 2853 2861 O
cardiac 35 42 2862 2869 O
function 43 51 2870 2878 O
based 52 57 2879 2884 O
upon 58 62 2885 2889 O
echocardiogram 63 77 2890 2904 B-treatment
or 78 80 2905 2907 O
gated 81 86 2908 2913 B-treatment
blood 87 92 2914 2919 I-treatment
pool 93 97 2920 2924 I-treatment
scan 98 102 2925 2929 I-treatment
( 103 104 2930 2931 O
multigated 104 114 2931 2941 B-treatment
acquisition 115 126 2942 2953 I-treatment
scan 127 131 2954 2958 I-treatment
[ 132 133 2959 2960 I-treatment
MUGA 133 137 2960 2964 I-treatment
] 137 138 2964 2965 I-treatment
) 138 139 2965 2966 O
with 140 144 2967 2971 O
an 145 147 2972 2974 O
ejection 148 156 2975 2983 B-clinical_variable
fraction 157 165 2984 2992 I-clinical_variable
> 166 167 2993 2994 O
= 167 168 2994 2995 O
50 169 171 2996 2998 B-lower_bound
% 171 172 2998 2999 I-lower_bound

Patients 0 8 3000 3008 O
must 9 13 3009 3013 O
have 14 18 3014 3018 O
received 19 27 3019 3027 O
at 28 30 3028 3030 O
least 31 36 3031 3036 O
1 37 38 3037 3038 B-lower_bound
prior 39 44 3039 3044 I-lower_bound
rituximab 45 54 3045 3054 B-treatment
- 54 55 3054 3055 O
based 55 60 3055 3060 O
immunochemotherapy 61 79 3061 3079 B-treatment
( 80 81 3080 3081 O
e.g. 81 85 3081 3085 O
, 85 86 3085 3086 O
R 87 88 3087 3088 B-treatment
- 88 89 3088 3089 I-treatment
CHOP 89 93 3089 3093 I-treatment
, 93 94 3093 3094 O
R 95 96 3095 3096 B-treatment
- 96 97 3096 3097 I-treatment
EPOCH 97 102 3097 3102 I-treatment
, 102 103 3102 3103 O
etc 104 107 3104 3107 O
. 107 108 3107 3108 O
) 108 109 3108 3109 O

Patients 0 8 3110 3118 O
must 9 13 3119 3123 O
not 14 17 3124 3127 O
have 18 22 3128 3132 O
any 23 26 3133 3136 O
significant 27 38 3137 3148 O
toxicity 39 47 3149 3157 O
associated 48 58 3158 3168 O
with 59 63 3169 3173 O
prior 64 69 3174 3179 B-treatment
surgery 70 77 3180 3187 I-treatment
, 77 78 3187 3188 O
radiation 79 88 3189 3198 B-treatment
therapy 89 96 3199 3206 I-treatment
, 96 97 3206 3207 O
chemotherapy 98 110 3208 3220 B-treatment
, 110 111 3220 3221 O
or 112 114 3222 3224 O
immunotherapy 115 128 3225 3238 B-treatment
, 128 129 3238 3239 O
per 130 133 3240 3243 O
principal 134 143 3244 3253 O
investigator 144 156 3254 3266 O
( 157 158 3267 3268 O
PI 158 160 3268 3270 O
) 160 161 3270 3271 O
discretion 162 172 3272 3282 O

Patients 0 8 3283 3291 O
who 9 12 3292 3295 O
test 13 17 3296 3300 O
positive 18 26 3301 3309 O
for 27 30 3310 3313 O
HBsAg 31 36 3314 3319 B-chronic_disease
are 37 40 3320 3323 O
ineligible 41 51 3324 3334 O
( 52 53 3335 3336 O
regardless 53 63 3336 3346 O
of 64 66 3347 3349 O
other 67 72 3350 3355 O
hepatitis 73 82 3356 3365 B-chronic_disease
B 83 84 3366 3367 I-chronic_disease
serologies 85 95 3368 3378 O
) 95 96 3378 3379 O

Patients 0 8 3380 3388 O
who 9 12 3389 3392 O
test 13 17 3393 3397 O
positive 18 26 3398 3406 O
for 27 30 3407 3410 O
hepatitis 31 40 3411 3420 B-chronic_disease
C 41 42 3421 3422 I-chronic_disease
( 43 44 3423 3424 I-chronic_disease
HepC 44 48 3424 3428 I-chronic_disease
) 48 49 3428 3429 I-chronic_disease
antibodies 50 60 3430 3440 I-chronic_disease
( 61 62 3441 3442 I-chronic_disease
Ab 62 64 3442 3444 I-chronic_disease
) 64 65 3444 3445 I-chronic_disease
are 66 69 3446 3449 O
eligible 70 78 3450 3458 O
provided 79 87 3459 3467 O
all 88 91 3468 3471 O
of 92 94 3472 3474 O
the 95 98 3475 3478 O
following 99 108 3479 3488 O
criteria 109 117 3489 3497 O
are 118 121 3498 3501 O
met 122 125 3502 3505 O
: 125 126 3505 3506 O
bilirubin 127 136 3507 3516 B-clinical_variable
= 137 138 3517 3518 O
< 138 139 3518 3519 O
2 140 141 3520 3521 B-upper_bound
x 142 143 3522 3523 I-upper_bound
upper 144 149 3524 3529 I-upper_bound
limit 150 155 3530 3535 I-upper_bound
of 156 158 3536 3538 I-upper_bound
normal 159 165 3539 3545 I-upper_bound
; 165 166 3545 3546 O
ALT 167 170 3547 3550 B-clinical_variable
/ 170 171 3550 3551 I-clinical_variable
AST 171 174 3551 3554 I-clinical_variable
= 175 176 3555 3556 O
< 176 177 3556 3557 O
3 178 179 3558 3559 B-upper_bound
x 180 181 3560 3561 I-upper_bound
upper 182 187 3562 3567 I-upper_bound
limit 188 193 3568 3573 I-upper_bound
of 194 196 3574 3576 I-upper_bound
normal 197 203 3577 3583 I-upper_bound
; 203 204 3583 3584 O
and 205 208 3585 3588 O
clinical 209 217 3589 3597 O
evaluation 218 228 3598 3608 O
to 229 231 3609 3611 O
rule 232 236 3612 3616 O
out 237 240 3617 3620 O
cirrhosis 241 250 3621 3630 B-chronic_disease

Patients 0 8 3631 3639 O
with 9 13 3640 3644 O
HBsAg 14 19 3645 3650 B-treatment
negative 20 28 3651 3659 O
, 28 29 3659 3660 O
but 30 33 3661 3664 O
HBcAb 34 39 3665 3670 B-treatment
positive 40 48 3671 3679 O
( 49 50 3680 3681 O
regardless 50 60 3681 3691 O
of 61 63 3692 3694 O
HBsAb 64 69 3695 3700 B-treatment
status 70 76 3701 3707 O
) 76 77 3707 3708 O
should 78 84 3709 3715 O
have 85 89 3716 3720 O
a 90 91 3721 3722 O
hepatitis 92 101 3723 3732 B-chronic_disease
B 102 103 3733 3734 I-chronic_disease
virus 104 109 3735 3740 I-chronic_disease
( 110 111 3741 3742 I-chronic_disease
HBV 111 114 3742 3745 I-chronic_disease
) 114 115 3745 3746 I-chronic_disease
deoxyribonucleic 116 132 3747 3763 B-treatment
acid 133 137 3764 3768 I-treatment
( 138 139 3769 3770 I-treatment
DNA 139 142 3770 3773 I-treatment
) 142 143 3773 3774 I-treatment
testing 144 151 3775 3782 O
done 152 156 3783 3787 O
and 157 160 3788 3791 O
protocol 161 169 3792 3800 O

Patients 0 8 3801 3809 O
with 9 13 3810 3814 O
non 14 17 3815 3818 B-cancer
- 17 18 3818 3819 I-cancer
Hodgkin 18 25 3819 3826 I-cancer
lymphoma 26 34 3827 3835 I-cancer
( 35 36 3836 3837 I-cancer
NHL 36 39 3837 3840 I-cancer
) 39 40 3840 3841 I-cancer
other 41 46 3842 3847 O
than 47 51 3848 3852 O
DLBCL 52 57 3853 3858 B-cancer
; 57 58 3858 3859 O
including 59 68 3860 3869 O
transformed 69 80 3870 3881 O
DLBCL 81 86 3882 3887 O

Peripheral 0 10 3888 3898 B-chronic_disease
neuropathy 11 21 3899 3909 I-chronic_disease
of 22 24 3910 3912 O
grade 25 30 3913 3918 B-lower_bound
2 31 32 3919 3920 I-lower_bound
or 33 35 3921 3923 O
greater 36 43 3924 3931 O
severity 44 52 3932 3940 O
as 53 55 3941 3943 O
defined 56 63 3944 3951 O
by 64 66 3952 3954 O
the 67 70 3955 3958 O
National 71 79 3959 3967 O
Cancer 80 86 3968 3974 O
Institute 87 96 3975 3984 O
's 96 98 3984 3986 O
( 99 100 3987 3988 O
NCI 100 103 3988 3991 O
) 103 104 3991 3992 O
Common 105 111 3993 3999 O
Terminology 112 123 4000 4011 O
Criteria 124 132 4012 4020 O
for 133 136 4021 4024 O
Adverse 137 144 4025 4032 O
Events 145 151 4033 4039 O
( 152 153 4040 4041 O
CTCAE 153 158 4041 4046 O
) 158 159 4046 4047 O
version 160 167 4048 4055 O
4.0 168 171 4056 4059 O

Platelet 0 8 4060 4068 B-clinical_variable
count 9 14 4069 4074 I-clinical_variable
> 15 16 4075 4076 O
= 16 17 4076 4077 O
50 18 20 4078 4080 B-lower_bound
x 21 22 4081 4082 I-lower_bound
10 23 25 4083 4085 I-lower_bound
^ 25 26 4085 4086 I-lower_bound
9 26 27 4086 4087 I-lower_bound
/ 27 28 4087 4088 I-lower_bound
L 28 29 4088 4089 I-lower_bound
( 30 31 4090 4091 O
> 31 32 4091 4092 O
= 32 33 4092 4093 O
20 34 36 4094 4096 B-lower_bound
x 37 38 4097 4098 I-lower_bound
10 39 41 4099 4101 I-lower_bound
^ 41 42 4101 4102 I-lower_bound
9 42 43 4102 4103 I-lower_bound
/ 43 44 4103 4104 I-lower_bound
L 44 45 4104 4105 I-lower_bound
if 46 48 4106 4108 O
lymphoma 49 57 4109 4117 B-cancer
involvement 58 69 4118 4129 O
in 70 72 4130 4132 O
the 73 76 4133 4136 O
pretreatment 77 89 4137 4149 B-treatment
bone 90 94 4150 4154 I-treatment
marrow 95 101 4155 4161 I-treatment
is 102 104 4162 4164 O
found 105 110 4165 4170 O
) 110 111 4170 4171 O
within 112 118 4172 4178 O
14 119 121 4179 4181 B-upper_bound
days 122 126 4182 4186 I-upper_bound
prior 127 132 4187 4192 I-upper_bound
to 133 135 4193 4195 O
starting 136 144 4196 4204 O
therapy 145 152 4205 4212 B-treatment

Pregnant 0 8 4213 4221 B-pregnancy

Prior 0 5 4222 4227 O
high 6 10 4228 4232 B-treatment
- 10 11 4232 4233 I-treatment
dose 11 15 4233 4237 I-treatment
chemotherapy 16 28 4238 4250 I-treatment
( 29 30 4251 4252 I-treatment
HDC)-ASCT 30 39 4252 4261 I-treatment

Serum 0 5 4262 4267 B-clinical_variable
alanine 6 13 4268 4275 I-clinical_variable
aminotransferase 14 30 4276 4292 I-clinical_variable
( 31 32 4293 4294 I-clinical_variable
ALT)/aspartate 32 46 4294 4308 I-clinical_variable
aminotransferase 47 63 4309 4325 I-clinical_variable
( 64 65 4326 4327 I-clinical_variable
AST 65 68 4327 4330 I-clinical_variable
) 68 69 4330 4331 I-clinical_variable
= 70 71 4332 4333 O
< 71 72 4333 4334 O
3.5 73 76 4335 4338 B-upper_bound
times 77 82 4339 4344 I-upper_bound
the 83 86 4345 4348 I-upper_bound
upper 87 92 4349 4354 I-upper_bound
limit 93 98 4355 4360 I-upper_bound
of 99 101 4361 4363 I-upper_bound
normal 102 108 4364 4370 I-upper_bound
within 109 115 4371 4377 O
14 116 118 4378 4380 B-upper_bound
days 119 123 4381 4385 I-upper_bound
prior 124 129 4386 4391 I-upper_bound
to 130 132 4392 4394 O
starting 133 141 4395 4403 O
therapy 142 149 4404 4411 B-treatment

Serum 0 5 4412 4417 B-clinical_variable
creatinine 6 16 4418 4428 I-clinical_variable
of 17 19 4429 4431 O
= 20 21 4432 4433 O
< 21 22 4433 4434 O
1.5 23 26 4435 4438 O
mg 27 29 4439 4441 O
/ 29 30 4441 4442 O
dL 30 32 4442 4444 O
; 32 33 4444 4445 O
if 34 36 4446 4448 O
creatinine 37 47 4449 4459 O
> 48 49 4460 4461 O
1.5 50 53 4462 4465 O
mg 54 56 4466 4468 O
/ 56 57 4468 4469 O
dL 57 59 4469 4471 O
creatinine 60 70 4472 4482 B-clinical_variable
clearance 71 80 4483 4492 I-clinical_variable
must 81 85 4493 4497 O
be 86 88 4498 4500 O
> 89 90 4501 4502 O
60 91 93 4503 4505 B-lower_bound
mL 94 96 4506 4508 I-lower_bound
/ 96 97 4508 4509 I-lower_bound
min 97 100 4509 4512 I-lower_bound
within 101 107 4513 4519 O
7 108 109 4520 4521 B-upper_bound
days 110 114 4522 4526 I-upper_bound
prior 115 120 4527 4532 I-upper_bound
to 121 123 4533 4535 O
treatment 124 133 4536 4545 B-treatment
either 134 140 4546 4552 O
measured 141 149 4553 4561 O
or 150 152 4562 4564 O
calculated 153 163 4565 4575 O
using 164 169 4576 4581 O
a 170 171 4582 4583 O
standard 172 180 4584 4592 O
Cockcroft 181 190 4593 4602 O
and 191 194 4603 4606 O
Gault 195 200 4607 4612 O
formula 201 208 4613 4620 O

Specific 0 8 4621 4629 O
guidelines 9 19 4630 4640 O
will 20 24 4641 4645 O
be 25 27 4646 4648 O
followed 28 36 4649 4657 O
regarding 37 46 4658 4667 O
inclusion 47 56 4668 4677 O
of 57 59 4678 4680 O
relapsed 60 68 4681 4689 O
/ 68 69 4689 4690 O
refractory 69 79 4690 4700 O
DLBCL 80 85 4701 4706 B-clinical_variable
based 86 91 4707 4712 O
on 92 94 4713 4715 O
hepatitis 95 104 4716 4725 B-chronic_disease
B 105 106 4726 4727 I-chronic_disease
serological 107 118 4728 4739 O
testing 119 126 4740 4747 O

Uncontrolled 0 12 4748 4760 O
intercurrent 13 25 4761 4773 O
illness 26 33 4774 4781 O
including 34 43 4782 4791 O
, 43 44 4791 4792 O
but 45 48 4793 4796 O
not 49 52 4797 4800 O
limited 53 60 4801 4808 O
to 61 63 4809 4811 O
, 63 64 4811 4812 O
active 65 71 4813 4819 B-chronic_disease
infection 72 81 4820 4829 I-chronic_disease
, 81 82 4829 4830 O
poorly 83 89 4831 4837 O
controlled 90 100 4838 4848 O
hypertension 101 113 4849 4861 B-chronic_disease
, 113 114 4861 4862 O
diabetes 115 123 4863 4871 B-chronic_disease
mellitus 124 132 4872 4880 I-chronic_disease
or 133 135 4881 4883 O
other 136 141 4884 4889 O
serious 142 149 4890 4897 O
medical 150 157 4898 4905 O
or 158 160 4906 4908 O
psychiatric 161 172 4909 4920 B-chronic_disease
conditions 173 183 4921 4931 I-chronic_disease
that 184 188 4932 4936 O
could 189 194 4937 4942 O
interfere 195 204 4943 4952 O
with 205 209 4953 4957 O
adherence 210 219 4958 4967 O
to 220 222 4968 4970 O
or 223 225 4971 4973 O
completion 226 236 4974 4984 O
of 237 239 4985 4987 O
this 240 244 4988 4992 O
study 245 250 4993 4998 O

patients 0 8 4999 5007 O
are 9 12 5008 5011 O
not 13 16 5012 5015 O
considered 17 27 5016 5026 O
to 28 30 5027 5029 O
have 31 35 5030 5034 O
a 36 37 5035 5036 O
currently 38 47 5037 5046 O
active 48 54 5047 5053 O
malignancy 55 65 5054 5064 B-cancer
if 66 68 5065 5067 O
they 69 73 5068 5072 O
have 74 78 5073 5077 O
completed 79 88 5078 5087 O
anti 89 93 5088 5092 B-treatment
- 93 94 5092 5093 I-treatment
cancer 94 100 5093 5099 I-treatment
therapy 101 108 5100 5107 I-treatment
, 108 109 5107 5108 O
are 110 113 5109 5112 O
considered 114 124 5113 5123 O
by 125 127 5124 5126 O
their 128 133 5127 5132 O
physician 134 143 5133 5142 O
to 144 146 5143 5145 O
be 147 149 5146 5148 O
at 150 152 5149 5151 O
less 153 157 5152 5156 O
than 158 162 5157 5161 O
30 163 165 5162 5164 B-upper_bound
% 165 166 5164 5165 I-upper_bound
risk 167 171 5166 5170 O
of 172 174 5171 5173 O
relapse 175 182 5174 5181 O
and 183 186 5182 5185 O
at 187 189 5186 5188 O
least 190 195 5189 5194 O
2 196 197 5195 5196 B-lower_bound
years 198 203 5197 5202 I-lower_bound
have 204 208 5203 5207 O
lapsed 209 215 5208 5214 O

patients 0 8 5215 5223 O
with 9 13 5224 5228 O
grade 14 19 5229 5234 B-lower_bound
2 20 21 5235 5236 I-lower_bound
or 22 24 5237 5239 O
higher 25 31 5240 5246 O
( 32 33 5247 5248 O
NCI 33 36 5248 5251 O
- 36 37 5251 5252 O
Common 37 43 5252 5258 B-clinical_variable
Toxicity 44 52 5259 5267 I-clinical_variable
Criteria 53 61 5268 5276 I-clinical_variable
[ 62 63 5277 5278 I-clinical_variable
CTC 63 66 5278 5281 I-clinical_variable
] 66 67 5281 5282 I-clinical_variable
) 67 68 5282 5283 O
neuropathy 69 79 5284 5294 O

should 0 6 5295 5301 O
a 7 8 5302 5303 O
woman 9 14 5304 5309 B-gender
become 15 21 5310 5316 B-pregnancy
pregnant 22 30 5317 5325 I-pregnancy
or 31 33 5326 5328 O
suspect 34 41 5329 5336 O
she 42 45 5337 5340 O
is 46 48 5341 5343 O
pregnant 49 57 5344 5352 O
while 58 63 5353 5358 O
she 64 67 5359 5362 O
or 68 70 5363 5365 O
her 71 74 5366 5369 O
partner 75 82 5370 5377 O
is 83 85 5378 5380 O
participating 86 99 5381 5394 O
in 100 102 5395 5397 O
this 103 107 5398 5402 O
study 108 113 5403 5408 O
, 113 114 5408 5409 O
she 115 118 5410 5413 O
should 119 125 5414 5420 O
inform 126 132 5421 5427 O
her 133 136 5428 5431 O
treating 137 145 5432 5440 O
physician 146 155 5441 5450 O
immediately 156 167 5451 5462 O

